AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more
November 19, 2021 04:55 AM AEDT| By Versha JainHighlights Cardiff Oncology, Inc. (NASDAQ: CRDF) stock jumped 21% in premarket Thursday. The company has received a US$15 million equity investment from Pfizer Inc. Cardiff plans to use the proceeds for its ongoing clinical research in KRAS-mu.....
Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket
November 19, 2021 03:18 AM AEDT| By Versha JainHighlights Novo Nordisk will acquire Dicerna Pharmaceuticals for US$3.3 billion. After the acquisition, Novo expects to begin the clinical development of its first investigational therapeutic in 2022. The transaction, which would be de.....
Progenity (PROG) stock continues rally, up 21%: Here’s why
November 18, 2021 03:32 AM AEDT| By Raza NaqviHighlights Progenity, Inc. (NASDAQ: PROG) will participate in Piper Sandler 33rd Annual Virtual Healthcare Conference The company's revenue surged over 220% in Q3, FY21 PROG stocks were up more than 20% in pre-market trading today The sto.....
Why did Altamira Therapeutics (CYTO) stock skyrocket today?
November 13, 2021 07:29 AM AEDT| By Ipsita SarkarHighlights Altamira Therapeutics Ltd. (NASDAQ: CYTO) announces positive test results for Bentrio nasal spray. The company received FDA approval for Bentrio on Oct 14. Altamira’s operating loss was about US$7.01 million for the six months.....
Eyeing for JNJ stock? Know why J&J is splitting into 2 companies
November 13, 2021 04:53 AM AEDT| By Ipsita SarkarHealthcare company Johnson & Johnson (NYSE: JNJ) announced on Friday to split the business into two companies in the next two years, triggering a flurry of speculation in the market. The stock jumped more than 2% in the premarket trading after.....
AstraZeneca (AZN) revenue skyrockets; is the stock worth exploring?
November 13, 2021 04:10 AM AEDT| By Versha JainHighlights AstraZeneca PLC (NASDAQ: AZN) revenue increased 50% YoY to US$9.877 billion in the third quarter ended September 30, 2021. However, it reported a loss of US$1.98 billion or US$(1.10) per share diluted in the quarter. AstraZenec.....
Is RenovoRx (RNXT) stock worth exploring? Know more.
November 11, 2021 05:49 AM AEDT| By Ipsita SarkarHighlights RenovoRx, Inc. (NASDAQ: RNXT) stock jumped over 66% in premarket on Wednesday. The company had made a presentation on its therapeutic platform a day earlier. RenovoRx, Inc. went public in August through a Nasdaq listing. Biopha.....
CVS (CVS), Humana (HUM) revise guidance after strong Q3 results
November 04, 2021 04:24 AM AEDT| By Versha JainHighlights CVS Health Corporation (NYSE: CVS) revenue rose 10% YoY to US$73.8 in Q3. Humana Inc. (NYSE: HUM) revenue rose 3% to US$20.7 billion in the third quarter. Both the companies have revised their full-year 2021 revenue guidance. .....
Pfizer (PFE) raises guidance after Q3 revenue jumps 134%
November 03, 2021 04:26 AM AEDT| By Versha JainHighlights Pfizer, Inc. (NYSE: PFE) revenue increased by 134% YoY to US$24.1 billion in Q3. The company raised guidance for fiscal 2021 after robust quarterly performance. On Oct 29, it received FDA approval for its covid booster dose, Comirna.....
Why did ABVC stock jump more than 200% today?
November 02, 2021 03:50 AM AEDT| By Versha JainABVC Biopharma, Inc. (NASDAQ: ABVC) jumped more than 219% on Monday after receiving approval from Taiwan Central Institutional Review Board to start Phase 2 trial of its attention-deficit ADHD drug. The stock traded at US$8.11, up 219.29% fro.....
AbbVie (ABBV) raises full-year guidance after Q3 revenue boost
October 30, 2021 04:09 AM AEDT| By Ipsita SarkarHighlights AbbVie Inc. (NYSE: ABBV) posted third-quarter revenue of US$14.342 billion, up 11.2% YoY. It raised the GAAP diluted EPS guidance to around US$6.29 to US$6.33 per share. ABBV also announced a dividend increase of 8.5% or US$1.41 pe.....
Merck (MRK), Sanofi (SNY) raise profit guidance after solid Q3 results
October 29, 2021 03:17 AM AEDT| By Ipsita SarkarHighlights Merck & Company, Inc’s (MRK) sales rose 20% YoY in Q3, FY21. Merck expects its adjusted annual profit to be between US$5.65 per share and US$5.70 per share. Sanofi (SNY) sales surged 10.1% YoY in Q3, FY21. Stocks of M.....
Bristol Myers (BMY), GlaxoSmithKline (GSK) post strong revenue growth
October 28, 2021 05:18 AM AEDT| By Ipsita SarkarHighlights Bristol-Myers Squibb Company (NYSE: BMY) revenue surged 10% YoY to US$11.5 billion in Q3, FY21. BMY raised its low-end adjusted EPS guidance by US$0.05 for fiscal 2021. GlaxoSmithKline PLC (NYSE: GSK) sales surged 10% YoY in Q3, FY2.....
Thermo Fisher (TMO), Boston Scientific (BSX) lift guidance after Q3 results
October 28, 2021 03:23 AM AEDT| By Ipsita SarkarHighlights Thermo Fisher Scientific Inc’s (NYSE: TMO) revenue increased by 9% YoY in Q3, FY21. TMO raised its revenue guidance for fiscal 2021 to US$37.1 billion. Boston Scientific Corp (NYSE: BSX) expects EPS in the range of US$0.21 to .....
Eli Lilly (LLY), Novartis (NVS) profits up on robust sales growth
October 27, 2021 03:07 AM AEDT| By Ipsita SarkarHighlights Eli Lilly and Company (NYSE: LLY) posted Q3 revenue of US$6.773 billion, up 18% YoY. Novartis AG’s (NYSE: NVS) net income rose 43% YoY to US$2.8 billion on net sales of US$13.0 billion. LLY raises revenue forecast for 2021; NV.....
Abbott (ABT), Anthem (ANTM) stocks rise after upbeat revenue outlook
October 21, 2021 03:23 AM AEDT| By Ipsita SarkarHighlights Abbott Laboratories’ (NYSE: ABT) third-quarter sales rose 23.4% to US$10.9 billion YoY. Abbott raised its full-year adjusted EPS guidance to between US$5.00 and US$5.10. Anthem, Inc’s (NYSE: ANTM) operating revenue jump.....
PROG, ADMP stocks jump after FDA approval, patent rights
October 19, 2021 11:12 AM AEDT| By Sanjeeb BaruahHighlights Progenity, Inc. (NASDAQ: PROG) secured four patents for ingestible technologies from the US Patent and Trademark Office (USPTO). The PROG stock grew nearly 47% since the patent announcement on October 13. Adamis Pharmaceuticals Cor.....
Seven stocks to explore as demand for healthcare soars
October 16, 2021 12:15 PM AEDT| By Ipsita SarkarHighlights CVS Health Corporation’s (NYSE: CVS) next ex-dividend date is Oct 21, 2021. Global Cord Blood Corporation’s (NYSE: CO) operating income was US$24.2 million in the June quarter of 2021. It added 19,673 new subscr.....
Why is the stock of gene-editing titan CRISPR hogging attention?
October 15, 2021 11:37 AM AEDT| By Sanjeeb BaruahSwiss-American biotechnology company CRISPR Therapeutics (NASDAQ: CRSP) has been gaining significant attention in recent days. While the stock has seen several ups and downs this week, it appeared on firmer ground on Thursday after closing the sess.....
Walgreens Boots (WBA) profits up 6.4% in Q4 as sales surge
October 15, 2021 09:19 AM AEDT| By Sanjeeb BaruahPharmacy chain operator Walgreens Boots Alliance Reports on Thursday reported a fourth-quarter profit of US$358 million after witnessing robust growth in the US and the UK markets. Walgreens’ net earnings from operations increased by 6.4% Yo.....
